InMed Pharmaceuticals INM
NASDAQ INM
$1.33 -0.02 (-1.48%)
At close: Oct 2, 2026 · 4:00 PM EDT

InMed Pharmaceuticals (INM) Gains from Sales and Divestitures (2019 - 2020)

Updated

InMed Pharmaceuticals' Gains from Sales and Divestitures was -$7,136 in FY2026 (year ended Jun 30, 2026).

Analysis

InMed Pharmaceuticals (INM) Gains from Sales and Divestitures (2019 - 2020) Analysis & Trends

From FY2020 onward, InMed Pharmaceuticals has reported Gains from Sales and Divestitures for 4 fiscal years.

  • The FY2026 figure marks the highest annual Gains from Sales and Divestitures since FY2021.
  • Per Business Quant data, Gains from Sales and Divestitures in earlier fiscal years was -$11,355 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Linde 221.03 Bn 204.14 Bn 4.43 Bn
2 Corning 141.47 Bn 134.60 Bn 1.63 Bn
3 Sherwin Williams 77.59 Bn 76.63 Bn 3.34 Bn
4 Air Products & Chemicals 61.84 Bn 59.74 Bn 1.04 Bn
5 LyondellBasell Industries 37.84 Bn 27.46 Bn 2.04 Bn
6 Nutrien 33.77 Bn 30.64 Bn 3.25 Bn
7 Qnity Electronics 27.51 Bn 24.93 Bn 666.00 Mn
8 Ati 26.21 Bn 24.36 Bn 309.80 Mn
9 Ppg Industries 23.37 Bn 16.17 Bn 1.81 Bn
10 InMed Pharmaceuticals 5.54 Mn 3.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 24.00
Mar 31, 2020 -1,521.00
Sep 30, 2019 -810.00
API Access

InMed Pharmaceuticals Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=INM&period=max&api_key=YOUR_API_KEY